Related Experiment Video
Updated: May 26, 2026
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic
1Reckitt & Colman Psychopharmacology Unit, The Medical School, University Walk, Bristol BS8 1TD, UK.
Abstract:
The clonidine challenge test is a means of assessing alpha-2-adrenoceptor sen sitivity in man. We review studies which have used this test to investigate central alpha-2- adrenoceptor changes in psychiatric illness, and to determine receptor changes after adminis tration and withdrawal of psychotropic treatments. Patients with severe depression show evidence of reduced alpha-2-adrenoceptor sensitivity, especially a reduced growth hormone response to clonidine. This may delineate a subgroup of patients with severe depressive illness from those with milder depression, and may even provide a trait marker for some depressed patients. Patients with panic disorder show evidence of subsensitivity to some and supersensitivity to other clonidine-induced responses. Other disorders, although less well investigated, may have abnormal test responses which may provide additional information about their cause and treatment. Changes in response after drug treatment have provided important information on the mode of action of antidepressants, and have suggested that noradrenergic function is altered by a variety of different antidepressants.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:25Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:26Psychosis: Goals of Pharmacotherapy
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:21Drugs Affecting Neurotransmitter Release or Uptake